Hopkins said that lenacapavir was expected to be reviewed by the U.S. Food and Drug Administration in 2025, with the potential to dramatically reduce HIV infection. "This will be a critical next step ...
The NR editors discuss the state of the political scene each week. Join former prosecutor Andy McCarthy as he delves into the legal ins and outs of the latest Washington dramas with National ...
It’s the foreign backlash made petty by Donald Trump’s red-carpet treatment as the already ... observed in a comprehensive report this week that the experience brought out a “distrust ...